141 related articles for article (PubMed ID: 32192772)
1. ROCK inhibitors enhance bone healing by promoting osteoclastic and osteoblastic differentiation.
Nakata J; Akiba Y; Nihara J; Thant L; Eguchi K; Kato H; Izumi K; Ohkura M; Otake M; Kakihara Y; Saito I; Saeki M
Biochem Biophys Res Commun; 2020 Jun; 526(3):547-552. PubMed ID: 32192772
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of ectopic bone formation in response to BMP-2 by Rho kinase inhibitor: a pilot study.
Yoshikawa H; Yoshioka K; Nakase T; Itoh K
Clin Orthop Relat Res; 2009 Dec; 467(12):3087-95. PubMed ID: 19609629
[TBL] [Abstract][Full Text] [Related]
3. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation.
Harmey D; Stenbeck G; Nobes CD; Lax AJ; Grigoriadis AE
J Bone Miner Res; 2004 Apr; 19(4):661-70. PubMed ID: 15005854
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats.
Ichikawa M; Yoshida J; Saito K; Sagawa H; Tokita Y; Watanabe M
Brain Res; 2008 Mar; 1201():23-33. PubMed ID: 18313036
[TBL] [Abstract][Full Text] [Related]
5. Alterations in osteocyte mediated osteoclastogenesis during estrogen deficiency and under ROCK-II inhibition: An in vitro study using a novel postmenopausal multicellular niche model.
Simfia I; Schiavi J; McNamara LM
Exp Cell Res; 2020 Jul; 392(1):112005. PubMed ID: 32330507
[TBL] [Abstract][Full Text] [Related]
6. Rho kinase inhibitors stimulate the migration of human cultured osteoblastic cells by regulating actomyosin activity.
Zhang X; Li C; Gao H; Nabeka H; Shimokawa T; Wakisaka H; Matsuda S; Kobayashi N
Cell Mol Biol Lett; 2011 Jun; 16(2):279-95. PubMed ID: 21394446
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase inhibition: a new approach for treating diabetic nephropathy?
Bach LA
Diabetes; 2008 Mar; 57(3):532-3. PubMed ID: 18305148
[No Abstract] [Full Text] [Related]
8. ROCK-II inhibition suppresses impaired mechanobiological responses in early estrogen deficient osteoblasts.
Simfia I; Schiavi J; McNamara LM
Exp Cell Res; 2020 Nov; 396(1):112264. PubMed ID: 32898551
[TBL] [Abstract][Full Text] [Related]
9. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY
Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863
[TBL] [Abstract][Full Text] [Related]
10. [Rho-kinase inhibitors].
Seto M; Asano T
Nihon Yakurigaku Zasshi; 2011 Sep; 138(3):112-6. PubMed ID: 21908938
[No Abstract] [Full Text] [Related]
11. [Rho-kinase inhibitor].
Ohnaka K; Takayanagi R
Nihon Rinsho; 2004 Feb; 62 Suppl 2():571-4. PubMed ID: 15035192
[No Abstract] [Full Text] [Related]
12. Signaling through Rho GTPase pathway as viable drug target.
Lu Q; Longo FM; Zhou H; Massa SM; Chen YH
Curr Med Chem; 2009; 16(11):1355-65. PubMed ID: 19355891
[TBL] [Abstract][Full Text] [Related]
13. Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts.
Natsume H; Tokuda H; Adachi S; Takai S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Niida S; Mizutani J; Kozawa O; Otsuka T
Bone; 2010 Apr; 46(4):1068-74. PubMed ID: 20114091
[TBL] [Abstract][Full Text] [Related]
14. Rho-kinase inhibitors augment the inhibitory effect of propofol on rat bronchial smooth muscle contraction.
Hanazaki M; Yokoyama M; Morita K; Kohjitani A; Sakai H; Chiba Y; Misawa M
Anesth Analg; 2008 Jun; 106(6):1765-71. PubMed ID: 18499607
[TBL] [Abstract][Full Text] [Related]
15. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
16. [Advances in the study of Rho kinase and its inhibitors].
Duan WG; Yuan ST; Liao H; Yan M; Zhang LY
Yao Xue Xue Bao; 2007 Oct; 42(10):1013-22. PubMed ID: 18229604
[TBL] [Abstract][Full Text] [Related]
17. RhoA and Rho-kinase inhibitors modulate cervical resistance: The possible role of RhoA/Rho-kinase signalling pathway in cervical ripening and contractility.
Domokos D; Ducza E; Gáspár R
Eur J Pharmacol; 2019 Jan; 843():27-33. PubMed ID: 30445018
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells.
Yamaguchi S; Tanabe K; Takai S; Matsushima-Nishiwaki R; Adachi S; Iida H; Kozawa O; Dohi S
Neurochem Int; 2009 Nov; 55(6):438-45. PubMed ID: 19427347
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
[TBL] [Abstract][Full Text] [Related]
20. Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.
Heikkila T; Wheatley E; Crighton D; Schroder E; Boakes A; Kaye SJ; Mezna M; Pang L; Rushbrooke M; Turnbull A; Olson MF
PLoS One; 2011; 6(9):e24825. PubMed ID: 21949762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
